Indoleamine 2,3-dioxygenase (IDO) Inhibitors

Indoleamine 23-dioxygenase (IDO) inhibitors are powerful pharmaceutical agents that target and inhibit the activity of the IDO enzyme IDO is a key player in the immunosuppressive pathways of the body and its overexpression has been implicated in various diseases including cancer By blocking IDO these inhibitors have the potential to enhance the immune response against tumor cells thus offering a promising approach for cancer immunotherapy Our company specializes in developing high-quality IDO inhibitors that have demonstrated significant efficacy in preclinical and clinical trials providing hope for improved treatment options and better outcomes for patients

Catalog Number	Chemical Name	CAS #	Price
EI-0430	BMS-986205	1923833-60-6	Online Inquiry
EI-1199	IDO Pathway inhibitor	110117-83-4	Online Inquiry
EI-1200	IDO-IN-2	1668565-74-9	Online Inquiry
EI-1201	IDO1 Inhibitor I	914471-09-3	Online Inquiry
EI-1212	INCB-024360	1204669-58-8	Online Inquiry
EI-1395	LY-3381916	2166616-75-5	Online Inquiry
EI-1433	Menadione	58-27-5	Online Inquiry
EI-1575	NLG919	1402836-58-1	Online Inquiry
EI-1732	PF-06840003	198474-05-4	Online Inquiry

Application

Indoleamine 23-dioxygenase (IDO) inhibitors have tremendous potential in both research and medicine In the field of research these inhibitors are widely used to investigate the role of the IDO enzyme in various biological processes and diseases By inhibiting IDO activity scientists can gain valuable insights into the impact of this enzyme on immune responses cancer progression and inflammation among other areas of study

In medicine IDO inhibitors are being explored as a promising therapeutic approach for a range of conditions IDO has been implicated in immune evasion by tumors and inhibiting its activity can potentially enhance the body's immune response against cancer cells Furthermore IDO inhibitors have shown potential in mitigating the negative effects of immune checkpoint inhibitors and improving their efficacy in cancer treatment

In addition to their application in cancer research and treatment IDO inhibitors hold promise in the field of neurology Neuroinflammation is a common feature in several neurological disorders and IDO has emerged as a key player in this process By inhibiting IDO researchers hope to mitigate neuroinflammation and potentially alleviate symptoms associated with conditions like Alzheimer's disease and multiple sclerosis

Overall the versatile applications of IDO inhibitors make them an essential tool for understanding biological processes and developing novel therapies in both research and medicine

Please note that all services are for research use only. Not intended for any clinical use.

Indoleamine 2,3-dioxygenase (IDO) Inhibitors